Spots Global Cancer Trial Database for Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
Official Title: Open-label Trial of Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
Study ID: NCT00928525
Interventions
Study Description
Brief Summary: The purpose of this study is to determine whether Imatinib Mesylate is active in diseases - such as Desmoid Tumor and Chondrosarcoma - expressing the receptor for the platelet-derived growth factor (PDGF) both in its isoform alpha and beta
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Centro di Riferimento Oncologico - Unit of Medical Oncology, Aviano, Pordenone, Italy
I.R.C.C. - Unit of Medical Oncology, Candiolo, Torino, Italy
Istituti Ortopedici Rizzoli - Unit of chemotherapy of Muscoloskeletal Tumors, Bologna, , Italy
Policlinico S.Orsola Malpighi - Unit of Medical Oncology, Bologna, , Italy
Istituto Nazionale Tumori - Unit of Medical Oncology, Milano, , Italy
Istituto Nazionale Tumori Regina Elena - Unit of Medical Oncology I, Roma, , Italy
Ospedale Gradenigo - Unit of Medical Oncology, Torino, , Italy
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
